INPP4B and plasma cell myeloma: Most recently, Wang et al. demonstrated that INPP4B overexpression decreased the phosphorylation of AKT in multiple myeloma and hepatocellular carcinoma cells [31], whereas tumors derived from INPP4B knockout mice were found to be enriched for AKT [25].